))
Risk of bias in tobacco cessation trials with Jamie Hartmann-Boyce
Manage episode 386494405 series 3532152
Rob Calder and Addiction journal에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Rob Calder and Addiction journal 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
In this episode, Chloe Burke talks to Dr Jamie Hartmann-Boyce about new guidance from the Cochrane Tobacco Addiction Group (TAG) on assessing and minimising risk of bias in tobacco cessation trials. Jamie explains some of the key challenges in this area and explains some of the primary sources of bias that authors need to be aware of when analysing tobacco cessation trials. This article was published as part of Addiction's Methods and Techniques series.
"We wanted to do this to make sure people were assessing it [risk of bias] well, but also to put in some sort of consistency across our reviews so that the different author teams working on them were broadly using the same criteria"
Original article: Assessing and minimizing risk of bias in randomized controlled trials of tobacco cessation interventions: Guidance from the Cochrane Tobacco Addiction Group by Jamie Hartmann-Boyce and Nicola Lindson. Published in Addiction (2023)
Hosted on Acast. See acast.com/privacy for more information.
101 에피소드
공유
